Article 06 Nov 2018 Legal Fees Spent Successfully Defending Qui Tam Whistleblower Claims May Be Recoverable Even Under Fixed-Price Contracts United States Government
Article 29 Jan 2018 New "Granston Memorandum" Outlines Factors DOJ May Consider In Dismissing Qui Tam Cases Brought By Relators United States IP
Article 29 Jan 2018 DOJ Granston Memorandum May Promote Dismissal Of Unmeritorious FCA Qui Tam Lawsuits United States Healthcare
Article 09 Jun 2017 What VA Contractors Can Expect from Proposed Amendments to VA Acquisition Regulations United States Government
Article 26 Apr 2016 Acquisition Of Some Non-TAA-Compliant Drugs To Be Permitted By Veterans Affairs United States Healthcare
Article 26 Apr 2016 New VA Policy To Have Immediate Impact On Many Pharmaceutical Manufacturers, Suppliers United States Healthcare
Article 25 Apr 2016 Veterans Affairs To Permit Acquisition Of Non-TAA-Compliant Drugs United States Healthcare
Article 05 Feb 2016 The Supreme Court's Recent Confirmation that Yearsley Derivative Sovereign Immunity Extends Beyond Public Works Projects United States Government
Article 03 Feb 2016 The Supreme Court's Recent Confirmation That Yearsley Derivative Sovereign Immunity Extends Beyond Public Works Projects United States Government
Article 19 Mar 2015 Medical Device Companies Face Severe FCA Penalties For TAA Violations United States Healthcare
Article 08 Oct 2014 U.S. Supreme Court Upholds Fourth Circuit Victory For Omnicare, Inc. In High-Profile, Precedent-Setting False Claims Act Case United States Healthcare
Article 17 Mar 2014 Are Internal Compliance Investigations Privileged? D.C. District Court Rules No United States Commercial
Article 27 Feb 2014 Federal Appeals Court Rejects False Claims Act Suit Based on Drug Packaging cGMP Violations United States Criminal